EBS

EBS CapEx to Revenue

1.53%TTM

Retrieved:

EBS FY CapEx/Revenue%
EBS FY CapEx/Revenue556.18%-59.59%
2001-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

EBS capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 25 observations from Dec 31, 2001 to Dec 31, 2025.

Emergent Biosolutions Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
1.8576%
2.1943%
4.9176%
10.3624%
12.6861%
8.9964%
7.8571%
9.2152%
9.775%
15.6009%
9.1578%
7.5836%
13.4362%
19.1016%
19.7619%
7.723%
14.1776%
11.6564%
24.0379%
26.9937%
4.9982%
20.447%
0%
0%
496.5901%

Compare capex to revenue

All EBS financial metrics · EBS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.